Global Deuterated Drugs Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
A deuterated drug is a small molecule medicinal product in which one or more of the hydrogen atoms contained in the drug molecule have been replaced by its heavier stable isotope deuterium. Because of the kinetic isotope effect, deuterium-containing drugs may have significantly lower rates of metabolism, and hence a longer half-life.
According to this study, the global Deuterated Drugs market size will reach US$ million by 2029.
This report presents a comprehensive overview, market shares, and growth opportunities of Deuterated Drugs market by product type, application, key players and key regions and countries.
Segmentation by product type:
A deuterated drug is a small molecule medicinal product in which one or more of the hydrogen atoms contained in the drug molecule have been replaced by its heavier stable isotope deuterium. Because of the kinetic isotope effect, deuterium-containing drugs may have significantly lower rates of metabolism, and hence a longer half-life.
According to this study, the global Deuterated Drugs market size will reach US$ million by 2029.
This report presents a comprehensive overview, market shares, and growth opportunities of Deuterated Drugs market by product type, application, key players and key regions and countries.
Segmentation by product type:
- Austedo
- Zepsun
- Others
- Huntington'S Disease (HD)
- Tardive Dyskinesia (TD)
- Cancer
- Others
- United States
- China
- Europe
- Other regions:
- Japan
- South Korea
- Southeast Asia
- Rest of world
- Teva
- Suzhou Zelgen Biopharmaceuticals
- Concert Pharmaceuticals
- Vertex Pharmaceuticals
- Hinova Pharma
- Otsuka Pharmaceutical (Avanir)
- Poxel SA (DeuteRx)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Deuterated Drugs Market Size 2024-2029
2.1.2 Deuterated Drugs Market Size CAGR by Region
2.2 Deuterated Drugs Segment by Type
2.2.1 Austedo
2.2.2 Zepsun
2.2.3 Others
2.3 Deuterated Drugs Market Size by Type
2.3.1 Global Deuterated Drugs Market Size Market Share by Type (2024-2029)
2.3.2 Global Deuterated Drugs Market Size Growth Rate by Type (2024-2029)
2.4 Deuterated Drugs Segment by Application
2.4.1 Huntington'S Disease (HD)
2.4.2 Tardive Dyskinesia (TD)
2.4.3 Cancer
2.4.4 Others
2.5 Deuterated Drugs Market Size by Application
2.5.1 Global Deuterated Drugs Market Size Market Share by Application (2024-2029)
2.5.2 Global Deuterated Drugs Market Size Growth Rate by Application (2024-2029)
3 DEUTERATED DRUGS KEY PLAYERS
3.1 Date of Key Players Enter into Deuterated Drugs
3.2 Key Players Deuterated Drugs Product Offered
3.3 Key Players Deuterated Drugs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Deuterated Drugs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 DEUTERATED DRUGS BY REGIONS
4.1 Deuterated Drugs Market Size by Regions (2024-2029)
4.2 United States Deuterated Drugs Market Size Growth (2024-2029)
4.3 China Deuterated Drugs Market Size Growth (2024-2029)
4.4 Europe Deuterated Drugs Market Size Growth (2024-2029)
4.5 Rest of World Deuterated Drugs Market Size Growth (2024-2029)
5 UNITED STATES
5.1 United States Deuterated Drugs Market Size by Type (2024-2029)
5.2 United States Deuterated Drugs Market Size by Application (2024-2029)
6 EUROPE
6.1 Europe Deuterated Drugs Market Size by Type (2024-2029)
6.2 Europe Deuterated Drugs Market Size by Application (2024-2029)
7 CHINA
7.1 China Deuterated Drugs Market Size by Type (2024-2029)
7.2 China Deuterated Drugs Market Size by Application (2024-2029)
8 REST OF WORLD
8.1 Rest of World Deuterated Drugs Market Size by Type (2024-2029)
8.2 Rest of World Deuterated Drugs Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 KEY INVESTORS IN DEUTERATED DRUGS
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Deuterated Drugs Product Offered
11.1.3 Teva Deuterated Drugs Market Size (2023 VS 2029)
11.1.4 Teva Main Business Overview
11.1.5 Teva News
11.2 Suzhou Zelgen Biopharmaceuticals
11.2.1 Suzhou Zelgen Biopharmaceuticals Company Details
11.2.2 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Product Offered
11.2.3 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
11.2.4 Suzhou Zelgen Biopharmaceuticals Main Business Overview
11.2.5 Suzhou Zelgen Biopharmaceuticals News
11.3 Concert Pharmaceuticals
11.3.1 Concert Pharmaceuticals Company Details
11.3.2 Concert Pharmaceuticals Deuterated Drugs Product Offered
11.3.3 Concert Pharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
11.3.4 Concert Pharmaceuticals Main Business Overview
11.3.5 Concert Pharmaceuticals News
11.4 Vertex Pharmaceuticals
11.4.1 Vertex Pharmaceuticals Company Details
11.4.2 Vertex Pharmaceuticals Deuterated Drugs Product Offered
11.4.3 Vertex Pharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
11.4.4 Vertex Pharmaceuticals Main Business Overview
11.4.5 Vertex Pharmaceuticals News
11.5 Hinova Pharma
11.5.1 Hinova Pharma Company Details
11.5.2 Hinova Pharma Deuterated Drugs Product Offered
11.5.3 Hinova Pharma Deuterated Drugs Market Size (2023 VS 2029)
11.5.4 Hinova Pharma Main Business Overview
11.5.5 Hinova Pharma News
11.6 Otsuka Pharmaceutical (Avanir)
11.6.1 Otsuka Pharmaceutical (Avanir) Company Details
11.6.2 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Product Offered
11.6.3 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Market Size (2023 VS 2029)
11.6.4 Otsuka Pharmaceutical (Avanir) Main Business Overview
11.6.5 Otsuka Pharmaceutical (Avanir) News
11.7 Poxel SA (DeuteRx)
11.7.1 Poxel SA (DeuteRx) Company Details
11.7.2 Poxel SA (DeuteRx) Deuterated Drugs Product Offered
11.7.3 Poxel SA (DeuteRx) Deuterated Drugs Market Size (2023 VS 2029)
11.7.4 Poxel SA (DeuteRx) Main Business Overview
11.7.5 Poxel SA (DeuteRx) News
...
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Deuterated Drugs Market Size 2024-2029
2.1.2 Deuterated Drugs Market Size CAGR by Region
2.2 Deuterated Drugs Segment by Type
2.2.1 Austedo
2.2.2 Zepsun
2.2.3 Others
2.3 Deuterated Drugs Market Size by Type
2.3.1 Global Deuterated Drugs Market Size Market Share by Type (2024-2029)
2.3.2 Global Deuterated Drugs Market Size Growth Rate by Type (2024-2029)
2.4 Deuterated Drugs Segment by Application
2.4.1 Huntington'S Disease (HD)
2.4.2 Tardive Dyskinesia (TD)
2.4.3 Cancer
2.4.4 Others
2.5 Deuterated Drugs Market Size by Application
2.5.1 Global Deuterated Drugs Market Size Market Share by Application (2024-2029)
2.5.2 Global Deuterated Drugs Market Size Growth Rate by Application (2024-2029)
3 DEUTERATED DRUGS KEY PLAYERS
3.1 Date of Key Players Enter into Deuterated Drugs
3.2 Key Players Deuterated Drugs Product Offered
3.3 Key Players Deuterated Drugs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Deuterated Drugs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 DEUTERATED DRUGS BY REGIONS
4.1 Deuterated Drugs Market Size by Regions (2024-2029)
4.2 United States Deuterated Drugs Market Size Growth (2024-2029)
4.3 China Deuterated Drugs Market Size Growth (2024-2029)
4.4 Europe Deuterated Drugs Market Size Growth (2024-2029)
4.5 Rest of World Deuterated Drugs Market Size Growth (2024-2029)
5 UNITED STATES
5.1 United States Deuterated Drugs Market Size by Type (2024-2029)
5.2 United States Deuterated Drugs Market Size by Application (2024-2029)
6 EUROPE
6.1 Europe Deuterated Drugs Market Size by Type (2024-2029)
6.2 Europe Deuterated Drugs Market Size by Application (2024-2029)
7 CHINA
7.1 China Deuterated Drugs Market Size by Type (2024-2029)
7.2 China Deuterated Drugs Market Size by Application (2024-2029)
8 REST OF WORLD
8.1 Rest of World Deuterated Drugs Market Size by Type (2024-2029)
8.2 Rest of World Deuterated Drugs Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 KEY INVESTORS IN DEUTERATED DRUGS
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Deuterated Drugs Product Offered
11.1.3 Teva Deuterated Drugs Market Size (2023 VS 2029)
11.1.4 Teva Main Business Overview
11.1.5 Teva News
11.2 Suzhou Zelgen Biopharmaceuticals
11.2.1 Suzhou Zelgen Biopharmaceuticals Company Details
11.2.2 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Product Offered
11.2.3 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
11.2.4 Suzhou Zelgen Biopharmaceuticals Main Business Overview
11.2.5 Suzhou Zelgen Biopharmaceuticals News
11.3 Concert Pharmaceuticals
11.3.1 Concert Pharmaceuticals Company Details
11.3.2 Concert Pharmaceuticals Deuterated Drugs Product Offered
11.3.3 Concert Pharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
11.3.4 Concert Pharmaceuticals Main Business Overview
11.3.5 Concert Pharmaceuticals News
11.4 Vertex Pharmaceuticals
11.4.1 Vertex Pharmaceuticals Company Details
11.4.2 Vertex Pharmaceuticals Deuterated Drugs Product Offered
11.4.3 Vertex Pharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
11.4.4 Vertex Pharmaceuticals Main Business Overview
11.4.5 Vertex Pharmaceuticals News
11.5 Hinova Pharma
11.5.1 Hinova Pharma Company Details
11.5.2 Hinova Pharma Deuterated Drugs Product Offered
11.5.3 Hinova Pharma Deuterated Drugs Market Size (2023 VS 2029)
11.5.4 Hinova Pharma Main Business Overview
11.5.5 Hinova Pharma News
11.6 Otsuka Pharmaceutical (Avanir)
11.6.1 Otsuka Pharmaceutical (Avanir) Company Details
11.6.2 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Product Offered
11.6.3 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Market Size (2023 VS 2029)
11.6.4 Otsuka Pharmaceutical (Avanir) Main Business Overview
11.6.5 Otsuka Pharmaceutical (Avanir) News
11.7 Poxel SA (DeuteRx)
11.7.1 Poxel SA (DeuteRx) Company Details
11.7.2 Poxel SA (DeuteRx) Deuterated Drugs Product Offered
11.7.3 Poxel SA (DeuteRx) Deuterated Drugs Market Size (2023 VS 2029)
11.7.4 Poxel SA (DeuteRx) Main Business Overview
11.7.5 Poxel SA (DeuteRx) News
...
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Deuterated Drugs Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of Austedo
Table 3. Major Players of Zepsun
Table 4. Major Players of Others
Table 5. Global Deuterated Drugs Market Size by Type (2024-2029) ($ Millions)
Table 6. Global Deuterated Drugs Market Size Market Share by Type (2024-2029)
Table 7. Global Deuterated Drugs Market Size by Application (2024-2029) ($ Millions)
Table 8. Global Deuterated Drugs Market Size Market Share by Application (2024-2029)
Table 9. Date of Global Key Players Enter into Deuterated Drugs Market
Table 10. Global Key Players Deuterated Drugs Product Offered
Table 11. Key Players Deuterated Drugs Funding/Investment ($ Millions)
Table 12. Funding/Investment by Regions
Table 13. Funding/Investment by End Industry
Table 14. Key Players Deuterated Drugs Valuation & Market Capitalization ($ Millions)
Table 15. Key Players Mergers & Acquisitions, Expansion Plans
Table 16. Deuterated Drugs New Product/Technology Launches
Table 17. Deuterated Drugs Industry Partnerships, Agreements, and Collaborations
Table 18. Deuterated Drugs Industry Mergers and Acquisitions
Table 19. Global Deuterated Drugs Market Size by Regions 2024-2029 ($ Millions)
Table 20. Global Deuterated Drugs Market Size Market Share by Regions 2024-2029
Table 21. United States Deuterated Drugs Market Size by Type (2024-2029) ($ Millions)
Table 22. United States Deuterated Drugs Market Size Market Share by Type (2024-2029)
Table 23. United States Deuterated Drugs Market Size by Application (2024-2029) ($ Millions)
Table 24. United States Deuterated Drugs Market Size Market Share by Application (2024-2029)
Table 25. Europe Deuterated Drugs Market Size by Type (2024-2029) ($ Millions)
Table 26. Europe Deuterated Drugs Market Size Market Share by Type (2024-2029)
Table 27. Europe Deuterated Drugs Market Size by Application (2024-2029) ($ Millions)
Table 28. Europe Deuterated Drugs Market Size Market Share by Application (2024-2029)
Table 29. China Deuterated Drugs Market Size by Type (2024-2029) ($ Millions)
Table 30. China Deuterated Drugs Market Size Market Share by Type (2024-2029)
Table 31. China Deuterated Drugs Market Size by Application (2024-2029) ($ Millions)
Table 32. China Deuterated Drugs Market Size Market Share by Application (2024-2029)
Table 33. Rest of World Deuterated Drugs Market Size by Type (2024-2029) ($ Millions)
Table 34. Rest of World Deuterated Drugs Market Size Market Share by Type (2024-2029)
Table 35. Rest of World Deuterated Drugs Market Size by Application (2024-2029) ($ Millions)
Table 36. Rest of World Deuterated Drugs Market Size Market Share by Application (2024-2029)
Table 37. Key Market Drivers & Growth Opportunities of Deuterated Drugs
Table 38. Key Market Challenges & Risks of Deuterated Drugs
Table 39. Key Industry Trends of Deuterated Drugs
Table 40. Company A Company Details
Table 41. Companies Invested by Company A
Table 42. Company A Key Development and Market Layout
Table 43. Company B Company Details
Table 44. Companies Invested by Company B
Table 45. Company B Key Development and Market Layout
Table 46. Company C Company Details
Table 47. Companies Invested by Company C
Table 48. Company C Key Development and Market Layout
Table 49. Company C Company Details
Table 50. Companies Invested by Company C
Table 51. Company C Key Development and Market Layout
Table 52. Teva Basic Information, Head Office, Major Market Areas and Its Competitors
Table 53. Teva Deuterated Drugs Market Size (2023 VS 2029)
Table 54. Suzhou Zelgen Biopharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
Table 56. Concert Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Concert Pharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
Table 58. Vertex Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. Vertex Pharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
Table 60. Hinova Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. Hinova Pharma Deuterated Drugs Market Size (2023 VS 2029)
Table 62. Otsuka Pharmaceutical (Avanir) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Otsuka Pharmaceutical (Avanir) Deuterated Drugs Market Size (2023 VS 2029)
Table 64. Poxel SA (DeuteRx) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Poxel SA (DeuteRx) Deuterated Drugs Market Size (2023 VS 2029)
Table 1. Deuterated Drugs Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of Austedo
Table 3. Major Players of Zepsun
Table 4. Major Players of Others
Table 5. Global Deuterated Drugs Market Size by Type (2024-2029) ($ Millions)
Table 6. Global Deuterated Drugs Market Size Market Share by Type (2024-2029)
Table 7. Global Deuterated Drugs Market Size by Application (2024-2029) ($ Millions)
Table 8. Global Deuterated Drugs Market Size Market Share by Application (2024-2029)
Table 9. Date of Global Key Players Enter into Deuterated Drugs Market
Table 10. Global Key Players Deuterated Drugs Product Offered
Table 11. Key Players Deuterated Drugs Funding/Investment ($ Millions)
Table 12. Funding/Investment by Regions
Table 13. Funding/Investment by End Industry
Table 14. Key Players Deuterated Drugs Valuation & Market Capitalization ($ Millions)
Table 15. Key Players Mergers & Acquisitions, Expansion Plans
Table 16. Deuterated Drugs New Product/Technology Launches
Table 17. Deuterated Drugs Industry Partnerships, Agreements, and Collaborations
Table 18. Deuterated Drugs Industry Mergers and Acquisitions
Table 19. Global Deuterated Drugs Market Size by Regions 2024-2029 ($ Millions)
Table 20. Global Deuterated Drugs Market Size Market Share by Regions 2024-2029
Table 21. United States Deuterated Drugs Market Size by Type (2024-2029) ($ Millions)
Table 22. United States Deuterated Drugs Market Size Market Share by Type (2024-2029)
Table 23. United States Deuterated Drugs Market Size by Application (2024-2029) ($ Millions)
Table 24. United States Deuterated Drugs Market Size Market Share by Application (2024-2029)
Table 25. Europe Deuterated Drugs Market Size by Type (2024-2029) ($ Millions)
Table 26. Europe Deuterated Drugs Market Size Market Share by Type (2024-2029)
Table 27. Europe Deuterated Drugs Market Size by Application (2024-2029) ($ Millions)
Table 28. Europe Deuterated Drugs Market Size Market Share by Application (2024-2029)
Table 29. China Deuterated Drugs Market Size by Type (2024-2029) ($ Millions)
Table 30. China Deuterated Drugs Market Size Market Share by Type (2024-2029)
Table 31. China Deuterated Drugs Market Size by Application (2024-2029) ($ Millions)
Table 32. China Deuterated Drugs Market Size Market Share by Application (2024-2029)
Table 33. Rest of World Deuterated Drugs Market Size by Type (2024-2029) ($ Millions)
Table 34. Rest of World Deuterated Drugs Market Size Market Share by Type (2024-2029)
Table 35. Rest of World Deuterated Drugs Market Size by Application (2024-2029) ($ Millions)
Table 36. Rest of World Deuterated Drugs Market Size Market Share by Application (2024-2029)
Table 37. Key Market Drivers & Growth Opportunities of Deuterated Drugs
Table 38. Key Market Challenges & Risks of Deuterated Drugs
Table 39. Key Industry Trends of Deuterated Drugs
Table 40. Company A Company Details
Table 41. Companies Invested by Company A
Table 42. Company A Key Development and Market Layout
Table 43. Company B Company Details
Table 44. Companies Invested by Company B
Table 45. Company B Key Development and Market Layout
Table 46. Company C Company Details
Table 47. Companies Invested by Company C
Table 48. Company C Key Development and Market Layout
Table 49. Company C Company Details
Table 50. Companies Invested by Company C
Table 51. Company C Key Development and Market Layout
Table 52. Teva Basic Information, Head Office, Major Market Areas and Its Competitors
Table 53. Teva Deuterated Drugs Market Size (2023 VS 2029)
Table 54. Suzhou Zelgen Biopharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
Table 56. Concert Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Concert Pharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
Table 58. Vertex Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. Vertex Pharmaceuticals Deuterated Drugs Market Size (2023 VS 2029)
Table 60. Hinova Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. Hinova Pharma Deuterated Drugs Market Size (2023 VS 2029)
Table 62. Otsuka Pharmaceutical (Avanir) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Otsuka Pharmaceutical (Avanir) Deuterated Drugs Market Size (2023 VS 2029)
Table 64. Poxel SA (DeuteRx) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Poxel SA (DeuteRx) Deuterated Drugs Market Size (2023 VS 2029)
LIST OF FIGURES
Figure 1. Picture of Deuterated Drugs
Figure 2. Deuterated Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Deuterated Drugs Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. Deuterated Drugs Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global Deuterated Drugs Market Size Market Share by Type (2024-2029)
Figure 9. Global Austedo Market Size Growth Rate
Figure 10. Global Zepsun Market Size Growth Rate
Figure 11. Global Others Market Size Growth Rate
Figure 12. Deuterated Drugs in Huntington'S Disease (HD)
Figure 13. Global Deuterated Drugs Market: Huntington'S Disease (HD) (2024-2029) ($ Millions)
Figure 14. Deuterated Drugs in Tardive Dyskinesia (TD)
Figure 15. Global Deuterated Drugs Market: Tardive Dyskinesia (TD) (2024-2029) ($ Millions)
Figure 16. Deuterated Drugs in Cancer
Figure 17. Global Deuterated Drugs Market: Cancer (2024-2029) ($ Millions)
Figure 18. Deuterated Drugs in Others
Figure 19. Global Deuterated Drugs Market: Others (2024-2029) ($ Millions)
Figure 20. Global Deuterated Drugs Market Size Market Share by Application (2024-2029)
Figure 21. Global Deuterated Drugs Market Size in Huntington'S Disease (HD) Growth Rate
Figure 22. Global Deuterated Drugs Market Size in Tardive Dyskinesia (TD) Growth Rate
Figure 23. Global Deuterated Drugs Market Size in Cancer Growth Rate
Figure 24. Global Deuterated Drugs Market Size in Others Growth Rate
Figure 25. Funding/Investment
Figure 26. Global Deuterated Drugs Market Size Market Share by Regions 2024-2029
Figure 27. United States Deuterated Drugs Market Size 2024-2029 ($ Millions)
Figure 28. China Deuterated Drugs Market Size 2024-2029 ($ Millions)
Figure 29. Europe Deuterated Drugs Market Size 2024-2029 ($ Millions)
Figure 30. Rest of World Deuterated Drugs Market Size 2024-2029 ($ Millions)
Figure 31. United States Deuterated Drugs Consumption Market Share by Type in 2029
Figure 32. United States Deuterated Drugs Market Size Market Share by Application in 2029
Figure 33. China Deuterated Drugs Consumption Market Share by Type in 2029
Figure 34. China Deuterated Drugs Market Size Market Share by Application in 2029
Figure 35. Europe Deuterated Drugs Consumption Market Share by Type in 2029
Figure 36. Europe Deuterated Drugs Market Size Market Share by Application in 2029
Figure 37. Rest of World Deuterated Drugs Consumption Market Share by Type in 2029
Figure 38. Rest of World Deuterated Drugs Market Size Market Share by Application in 2029
Figure 1. Picture of Deuterated Drugs
Figure 2. Deuterated Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Deuterated Drugs Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. Deuterated Drugs Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global Deuterated Drugs Market Size Market Share by Type (2024-2029)
Figure 9. Global Austedo Market Size Growth Rate
Figure 10. Global Zepsun Market Size Growth Rate
Figure 11. Global Others Market Size Growth Rate
Figure 12. Deuterated Drugs in Huntington'S Disease (HD)
Figure 13. Global Deuterated Drugs Market: Huntington'S Disease (HD) (2024-2029) ($ Millions)
Figure 14. Deuterated Drugs in Tardive Dyskinesia (TD)
Figure 15. Global Deuterated Drugs Market: Tardive Dyskinesia (TD) (2024-2029) ($ Millions)
Figure 16. Deuterated Drugs in Cancer
Figure 17. Global Deuterated Drugs Market: Cancer (2024-2029) ($ Millions)
Figure 18. Deuterated Drugs in Others
Figure 19. Global Deuterated Drugs Market: Others (2024-2029) ($ Millions)
Figure 20. Global Deuterated Drugs Market Size Market Share by Application (2024-2029)
Figure 21. Global Deuterated Drugs Market Size in Huntington'S Disease (HD) Growth Rate
Figure 22. Global Deuterated Drugs Market Size in Tardive Dyskinesia (TD) Growth Rate
Figure 23. Global Deuterated Drugs Market Size in Cancer Growth Rate
Figure 24. Global Deuterated Drugs Market Size in Others Growth Rate
Figure 25. Funding/Investment
Figure 26. Global Deuterated Drugs Market Size Market Share by Regions 2024-2029
Figure 27. United States Deuterated Drugs Market Size 2024-2029 ($ Millions)
Figure 28. China Deuterated Drugs Market Size 2024-2029 ($ Millions)
Figure 29. Europe Deuterated Drugs Market Size 2024-2029 ($ Millions)
Figure 30. Rest of World Deuterated Drugs Market Size 2024-2029 ($ Millions)
Figure 31. United States Deuterated Drugs Consumption Market Share by Type in 2029
Figure 32. United States Deuterated Drugs Market Size Market Share by Application in 2029
Figure 33. China Deuterated Drugs Consumption Market Share by Type in 2029
Figure 34. China Deuterated Drugs Market Size Market Share by Application in 2029
Figure 35. Europe Deuterated Drugs Consumption Market Share by Type in 2029
Figure 36. Europe Deuterated Drugs Market Size Market Share by Application in 2029
Figure 37. Rest of World Deuterated Drugs Consumption Market Share by Type in 2029
Figure 38. Rest of World Deuterated Drugs Market Size Market Share by Application in 2029
